Laboratory Corporation of America Holdings (LH) - Total Assets

Latest as of March 2026: $19.09 Billion USD

Based on the latest financial reports, Laboratory Corporation of America Holdings (LH) holds total assets worth $19.09 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore LH strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Laboratory Corporation of America Holdings - Total Assets Trend (1989–2025)

This chart illustrates how Laboratory Corporation of America Holdings's total assets have evolved over time, based on quarterly financial data. Check Laboratory Corporation of America Holdin (LH) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Laboratory Corporation of America Holdings - Asset Composition Analysis

Current Asset Composition (December 2025)

Laboratory Corporation of America Holdings's total assets of $19.09 Billion consist of 21.9% current assets and 78.1% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $532.30 Million 2.9%
Accounts Receivable $2.26 Billion 12.3%
Inventory $534.70 Million 2.9%
Property, Plant & Equipment $3.08 Billion 16.8%
Intangible Assets $3.60 Billion 19.6%
Goodwill $6.79 Billion 36.9%

Asset Composition Trend (1989–2025)

This chart illustrates how Laboratory Corporation of America Holdings's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Laboratory Corporation of America Holdin stock valuation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Laboratory Corporation of America Holdings's current assets represent 21.9% of total assets in 2025, a decrease from 30.8% in 1989.
  • Cash Position: Cash and equivalents constituted 2.9% of total assets in 2025, down from 8.7% in 1989.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 55.0% of total assets, an increase from 0.0% in 1989.
  • Asset Diversification: The largest asset category is goodwill at 36.9% of total assets.

Laboratory Corporation of America Holdings Competitors by Total Assets

Key competitors of Laboratory Corporation of America Holdings based on total assets are shown below.

Company Country Total Assets
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
China CN¥9.20 Billion
SMO ClinPlus Co. Ltd.
SHE:301257
China CN¥1.52 Billion
Healius Ltd
AU:HLS
Australia AU$1.77 Billion
RHYTHM Biosciences Ltd
AU:RHY
Australia AU$3.10 Million
Check-Cap Ltd.
NASDAQ:MBAI
USA $7.49 Million
Sonic Healthcare Ltd
AU:SHL
Australia AU$17.03 Billion
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million

Laboratory Corporation of America Holdings - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.73 1.84 2.13
Quick Ratio 1.54 1.60 1.98
Cash Ratio 0.00 0.18 0.74
Working Capital $1.92 Billion $1.73 Billion $3.03 Billion

Laboratory Corporation of America Holdings - Advanced Valuation Insights

This section examines the relationship between Laboratory Corporation of America Holdings's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.39
Latest Market Cap to Assets Ratio 1.14
Asset Growth Rate (YoY) 0.1%
Total Assets $18.39 Billion
Market Capitalization $20.92 Billion USD

Valuation Analysis

Above Book Valuation: The market values Laboratory Corporation of America Holdings's assets above their book value (1.14x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Laboratory Corporation of America Holdings's assets grew by 0.1% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Laboratory Corporation of America Holdings (1989–2025)

The table below shows the annual total assets of Laboratory Corporation of America Holdings from 1989 to 2025.

Year Total Assets Change
2025-12-31 $18.39 Billion +0.07%
2024-12-31 $18.38 Billion +9.89%
2023-12-31 $16.73 Billion -17.02%
2022-12-31 $20.16 Billion -1.13%
2021-12-31 $20.39 Billion +1.56%
2020-12-31 $20.07 Billion +11.38%
2019-12-31 $18.02 Billion +11.34%
2018-12-31 $16.19 Billion -2.31%
2017-12-31 $16.57 Billion +16.29%
2016-12-31 $14.25 Billion -0.27%
2015-12-31 $14.29 Billion +95.65%
2014-12-31 $7.30 Billion +5.07%
2013-12-31 $6.95 Billion +2.05%
2012-12-31 $6.81 Billion +10.35%
2011-12-31 $6.17 Billion -0.27%
2010-12-31 $6.19 Billion +27.33%
2009-12-31 $4.86 Billion +4.07%
2008-12-31 $4.67 Billion +6.90%
2007-12-31 $4.37 Billion +9.18%
2006-12-31 $4.00 Billion +3.23%
2005-12-31 $3.88 Billion +7.63%
2004-12-31 $3.60 Billion +5.45%
2003-12-31 $3.41 Billion +30.75%
2002-12-31 $2.61 Billion +35.35%
2001-12-31 $1.93 Billion +15.76%
2000-12-31 $1.67 Billion +4.82%
1999-12-31 $1.59 Billion -3.09%
1998-12-31 $1.64 Billion -1.06%
1997-12-31 $1.66 Billion -13.48%
1996-12-31 $1.92 Billion +4.34%
1995-12-31 $1.84 Billion +81.42%
1994-12-31 $1.01 Billion +72.96%
1993-12-31 $585.50 Million +22.64%
1992-12-31 $477.40 Million +16.07%
1991-12-31 $411.30 Million +9.91%
1990-12-31 $374.20 Million +1.63%
1989-12-31 $368.20 Million --

About Laboratory Corporation of America Holdings

NYSE:LH USA Diagnostics & Research
Market Cap
$21.18 Billion
Market Cap Rank
#1230 Global
#501 in USA
Share Price
$258.25
Change (1 day)
-0.08%
52-Week Range
$243.04 - $290.93
All Time High
$290.93
About

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcoh… Read more